Fortrea Holdings Inc (FTRE)
19.13
-0.21
(-1.09%)
USD |
NASDAQ |
Nov 18, 13:15
Fortrea Holdings Revenue (Quarterly): 674.90M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 674.90M |
| June 30, 2024 | 662.40M |
| March 31, 2024 | 662.10M |
| December 31, 2023 | 976.20M |
| September 30, 2023 | 713.80M |
| June 30, 2023 | 725.10M |
| Date | Value |
|---|---|
| March 31, 2023 | 693.90M |
| December 31, 2022 | 761.70M |
| September 30, 2022 | 762.30M |
| June 30, 2022 | 793.10M |
| March 31, 2022 | 779.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
662.10M
Minimum
Mar 2024
976.20M
Maximum
Dec 2023
745.86M
Average
725.10M
Median
Jun 2023
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Illumina Inc | 1.08B |
| Lumos Pharma Inc | 0.726M |
| IQVIA Holdings Inc | 3.896B |
| Medpace Holdings Inc | 533.32M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.90M |
| Total Expenses (Quarterly) | 684.10M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | 2.754B |
| Gross Profit Margin (Quarterly) | 21.97% |
| Profit Margin (Quarterly) | -4.13% |
| Earnings Yield | -17.77% |
| Normalized Earnings Yield | -11.92 |